OMER Omeros Corporation
XNAS 16.51 DelayedStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
OMER
$16.51
—
Key stats
$16.51
- 52-Week Range
- $6.24 – $21.24
- YTD
- +0.79%
- IV Rank (30D)
- 13.12
- Straddle Price
- $2.98
- P/C Vol Ratio
- 0.33
- Market Cap
- $1.2B
- Open
- $16.80
- Day Range
- $16.42 – $16.80
- Volume
- 203,891
- Prev Close
- $16.86
Fair Value
MODEL: LONG
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.12% |
| Beta vs SPY | 1.60 |
| Cost of Equity (CAPM) | 13.91% (VRP-adj) |
| WACC | 13.68% |
| Volatility Risk Premium | +69.2pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 1.8% |
| Rev. Growth (YoY, DCF input) | +3.0% |
| DCF Horizon | 5 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.03 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $-0.1B |
| Return on Equity (TTM) | -243.1% |
| Book / Price | -3.8% |
| Gross Margin (TTM) | 96.4% |
| FCF Margin (TTM) | -178.9% |
| Quality Score | 1/6 — cyclical/struggling (5y DCF) |
| SMA 50 | $18.53 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $18.40 |
| Bollinger Width / SMA20 | 143.1% (drives anchor stability) |
| Net Debt | $0.0B |
| Market Cap | $1B |
Peers used for multiples: HRMY, JNJ, LGND, LLY, PFE, VTRS, XERS, ZTS
60-Day Conviction
60%
20-Day Fair Value
≈ by Nov 23, 2026
$16.51
α -0.1%
rank 62%
conviction
4%
40-Day Fair Value
≈ by Dec 22, 2026
$16.63
α +0.6%
rank 69%
conviction
17%
60-Day Fair Value
≈ by Jan 20, 2027
$16.81
α +1.7%
rank 65%
conviction
60%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $55.12 | 16% | median 35.2× · 6 peers |
| Peer EV/EBITDA | n/a | 0% | median 15.6× · 8 peers |
| Peer P/B | n/a | 0% | median 6.5× · 7 peers |
| Peer P/S | $2.33 | 25% | median 4.7× · 8 peers |
| Market Anchor (SMA50) | $18.53 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | $16.71 | 59% | 18 strikes · skew +0.18 |
As of 2026-10-23 · updated
Related
About
- Industry (SIC)
- PHARMACEUTICAL PREPARATIONS (2834) · industry map
- Exchange
- XNAS
- Market Cap
- $1.2B
- Employees
- 175
- List Date
- 2009-10-08
- CIK
- 0001285819
- Next Earnings
- 2026-11-12 (After-Close)
- EPS Forecast
- ($0.05) (1 est.)
- Headquarters
- Seattle, WA
- Homepage
- https://www.omeros.com
Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 34.02% | -14.16% | 16.94% | -1.52% | -12.40% | -28.63% | -0.96% |
| Feb | -2.49% | 12.50% | 30.90% | 32.35% | -0.24% | 2.82% | 12.64% |
| Mar | -8.29% | -15.35% | 31.36% | -27.82% | 0.61% | -11.85% | -5.22% |
| Apr | -2.91% | -42.55% | 25.54% | -1.25% | -7.08% | 20.86% | -1.23% |
| May | -14.66% | -26.41% | 9.54% | -1.18% | -55.98% | -26.69% | -19.23% |
| Jun | -3.32% | 13.64% | -25.27% | 0.00% | -2.60% | -11.29% | -4.81% |
| Jul | -7.41% | 7.33% | -17.14% | 36.46% | 30.30% | 23.59% | 12.19% |
| Aug | 8.81% | -10.44% | -17.03% | -16.14% | 15.24% | 49.60% | 5.01% |
| Sep | -13.81% | -27.75% | -17.51% | 0.00% | -4.43% | 1.55% | -10.33% |
| Oct | -26.58% | -5.16% | -57.04% | 5.76% | 77.05% | -10.48%* | -2.74% |
| Nov | 4.65% | -35.93% | 93.81% | 178.19% | 35.15% | -- | 55.17% |
| Dec | -5.72% | 7.62% | 46.64% | -17.32% | 77.43% | -- | 21.73% |
| Total | -39.61% | -82.16% | 43.08% | 155.56% | 113.42% | -14.54% | 29.29% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $18.22
SMA 50: $18.51
SMA 200: $13.36
Current: $16.51
EMA 12: $17.41
EMA 26: $17.90
MACD: -0.4968 | Signal: -0.3327
BEARISH
ADX (14): 21.58
WEAK TREND
+DI: 18.00
−DI: 29.97
Momentum Oscillators
RSI (14): 39.84
NEUTRAL
Stoch %K: 15.89
Stoch %D: 14.80
Williams %R: -84.87
Volume & Volatility
BB Upper: $20.64
BB Lower: $15.79
NEUTRAL
OBV: 153,860,276
Vol SMA 20: 1,072,619
Vol ROC: -74.45%
ATR: $0.85
True Range: $0.44
HV 20: 62.8%
HV 30: 70.9%
HV 60: 76.0%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-24T00:00:00 – 2026-10-22T00:00:00
AI Analysis
LLM Stock Analysis Report
Executive Summary
BULLISH (Confidence Level: 7/10)
Key drivers:
- Bullish MACD signal
- Strong trend indicators (ADX)
- Neutral RSI reading
- Positive options market sentiment
Primary risks:
- High volatility and beta
- Negative news sentiment surrounding investor alerts
- Potential earnings miss or regulatory issues
Investment thesis: OMER is poised for a potential breakout due to strong technical signals, despite negative news headlines. However, the high volatility and beta require caution.
Recent news sentiment impact: The negative news headlines have created a bearish narrative, which may be corrected if OMER can break above its SMA 20 or the upper Bollinger Band.
Technical Analysis
Trend Direction: Short-term: Bullish (SMA 20) Medium-term: Neutral (SMA 50 and SMA 200 trending sideways) Long-term: Bearish (SMA 200 trending downwards)
Support/Resistance Levels:
- Upper Bollinger Band: $19.88
- Middle Bollinger Band: $18.66
- Lower Bollinger Band: $17.44
Momentum Signals: RSI: 54.30 (neutral) MACD signal: Bullish (above the signal line) Bollinger Bands position: Neutral (price within the bands)
Volume Analysis: Volume SMA 20: 1501464.15 On-Balance Volume (OBV): 156111017.53 Volume Rate of Change: -69.07% (indicating decreased volume)
News & Sentiment Analysis
Recent Headlines Summary:
- Investor alerts and investigations surrounding OMER's business practices
- Positive articles on Heartflow vs. Omeros and Intellia Therapeutics vs. Omeros
Sentiment Assessment: Negative sentiment due to the recent investor alerts and investigations (60%)
Catalyst Identification: No specific catalysts identified, but potential earnings release or regulatory updates could impact the stock price.
Market Narrative: The negative news headlines have created a bearish narrative, which may be corrected if OMER can break above its SMA 20 or the upper Bollinger Band.
Risk & Volatility Assessment
Risk Level: High
Beta Interpretation: OMER is more volatile than the market (beta >1.99)
Volatility Regime: High volatility - stock moves more than market
Options Market Signals: IV rank: Low (11.1%) Put/call ratio: 0.94 (neutral sentiment) Unusual activity: None notable
Downside Protection: Support levels: SMA 20, middle Bollinger Band ($18.66), and lower Bollinger Band ($17.44)
Market Context & Positioning
Sector Performance: OMER is outperforming the broader market sector
Institutional Activity: Volume patterns suggesting institutional interest are mixed
Correlation Analysis: OMER has a moderate correlation with the market (R-squared = 0.47)
Relative Valuation: OMER is trading within its historical range, but above its 50-day moving average
Key Levels & Action Items
Critical Price Levels:
- SMA 20: $18.66
- Middle Bollinger Band: $18.66
- Lower Bollinger Band: $17.44
Breakout/Breakdown Levels: None notable
Time-Sensitive Catalysts: Earnings release (no specific date announced)
Risk Management: Stop-loss levels at the lower Bollinger Band ($17.44) and position sizing considerations based on volatility.
This comprehensive analysis provides a detailed assessment of OMER's technical, news, and risk factors. The bullish MACD signal, strong trend indicators, and positive options market sentiment suggest a potential breakout, while the high volatility and beta require caution. The negative news headlines surrounding investor alerts have created a bearish narrative, which may be corrected if OMER can break above its SMA 20 or the upper Bollinger Band.
Generated
News
All OMER news →
Earnings History
17 of 22 under expected move
Avg Expected Move
18.63%
Avg Actual Move
11.81%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-03-01 | After-Close | 17.52% | 3.97% | 0.23x | Within |
| 2021-05-10 | After-Close | 14.75% | 4.18% | 0.28x | Within |
| 2021-08-09 | After-Close | 16.86% | 2.62% | 0.16x | Within |
| 2021-11-09 | After-Close | 18.62% | 10.76% | 0.58x | Within |
| 2022-03-01 | After-Close | 23.52% | 3.80% | 0.16x | Within |
| 2022-05-10 | After-Close | 40.44% | 4.04% | 0.10x | Within |
| 2022-08-09 | After-Close | 29.35% | 20.32% | 0.69x | Within |
| 2022-11-09 | After-Close | 8.87% | 5.85% | 0.66x | Within |
| 2023-02-06 | After-Close | 22.09% | 3.01% | 0.14x | Within |
| 2023-05-09 | After-Close | 16.60% | 21.20% | 1.28x | Exceeded |
| 2023-08-09 | After-Close | 14.55% | 3.00% | 0.21x | Within |
| 2023-11-09 | After-Close | 24.60% | 0.79% | 0.03x | Within |
| 2024-04-01 | After-Close | 22.26% | 4.39% | 0.20x | Within |
| 2024-08-07 | After-Close | 13.25% | 5.78% | 0.44x | Within |
| 2024-11-13 | After-Close | 13.72% | 65.87% | 4.80x | Exceeded |
| 2025-03-31 | After-Close | 23.11% | 3.77% | 0.16x | Within |
| 2025-05-15 | After-Close | 13.92% | 18.61% | 1.34x | Exceeded |
| 2025-08-14 | After-Close | 12.14% | 7.04% | 0.58x | Within |
| 2025-11-13 | After-Close | 15.53% | 25.32% | 1.63x | Exceeded |
| 2026-01-07 | After-Close | 17.74% | 4.54% | 0.26x | Within |
| 2026-03-31 | After-Close | 16.10% | 14.39% | 0.89x | Within |
| 2026-08-12 | After-Close | 14.41% | 26.55% | 1.84x | Exceeded |
Earnings calendar: this week’s reports with expected vs actual moves →
OMER Options Activity & IV Rank
OMER IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 76.9%
7-DTE IV: —
Expected Move: $2.98
7-DTE Move: $2.98
Days to Exp: 28 (2026-11-20)
Options Flow
Call Volume: 1,242
Put Volume: 409
P/C Volume: 0.329
BULLISH
Call OI: 10,005
Put OI: 3,626
P/C OI: 0.362
Total OI: 13,631
ATM Options Pricing
ATM Call: $1.30
ATM Put: $1.68
Call %: 7.9%
Put %: 10.1%
Chain Summary
Chain Volume: 6,367
Chain OI: 59,326
Last Updated: 10/23/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Dealer Positioning
HIGH γ vs HISTORY
Estimated net dealer gamma is at the 82nd percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
82%
vs own history
GEX tilt
+0.45
OI-weighted, today
Vanna tilt
+0.22
δ-sensitivity to IV
Charm tilt
-0.40
δ-decay vs time
Charm tilt -0.40: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 37 ATM contracts, 12k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
No data
30 DTE / 10d
—
—
pts
EXTREME
ATM 78.9% / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)13.1LowOct 23
Straddle Price (30 DTE)$2.98Oct 23
Beta Analysis
Risk Metrics
Beta: 1.7292
Alpha: 105.65%
Correlation: 0.1983
R-Squared: 3.9%
Stock Volatility: 111.1%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own OMER
3 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Millennium Management Hedge fund Izzy Englander | $3.3M | #2293 of 3716 | -16.3% | 13F | |
| Citadel Hedge fund Ken Griffin | $814K | #3933 of 6285 | -67.1% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $4K | #4273 of 4729 | -52.8% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
OMER Institutional Ownership (13F)
Latest filings — 2026-09-30
? 13F Guide
Diluted shares outstanding: 79,285,344 (as of 2026-06-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
9 filers$22.38M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $9.24M | 41.28% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $4.51M | 20.15% | 2026-06-30 |
| 3 | KOTLER KEVIN | $3.79M | 16.96% | 2025-12-31 |
| 4 | Jane Street Group, LLC Custodian | $1.90M | 8.51% | 2026-06-30 |
| 5 | Caption Management, LLC | $1.15M | 5.12% | 2026-06-30 |
| 6 | PEAK6 LLC | $951.00K | 4.25% | 2026-06-30 |
| 7 | Wolverine Trading, LLC Custodian | $405.46K | 1.81% | 2025-09-30 |
| 8 | Walleye Capital LLC | $381.35K | 1.70% | 2026-06-30 |
| 9 | Sonora Investment Management Group, LLC | $49.20K | 0.22% | 2025-09-30 |
8 filers$31.58M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Affinity Asset Advisors, LLC | $13.42M | 42.50% | 2026-06-30 |
| 2 | Susquehanna International Group, LLP Custodian | $8.74M | 27.66% | 2026-06-30 |
| 3 | Caption Management, LLC | $3.46M | 10.96% | 2026-06-30 |
| 4 | Citadel Advisors LLC Custodian | $2.57M | 8.14% | 2026-06-30 |
| 5 | LMR Partners LLP | $1.38M | 4.38% | 2026-06-30 |
| 6 | Jane Street Group, LLC Custodian | $1.19M | 3.78% | 2026-06-30 |
| 7 | Walleye Capital LLC | $515.44K | 1.63% | 2026-06-30 |
| 8 | Wolverine Trading, LLC Custodian | $295.94K | 0.94% | 2025-09-30 |
OMER Insider Trading (Form 4)
Latest: 2026-09-24Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-24 | David J. Borges | VP, Finance & CAO | Mixed | — | $15.23 | -$228.8K | EDGAR |
| 2026-09-01 | Peter B Cancelmo | VP, General Counsel | Mixed | — | $10.77 | -$782.7K | EDGAR |
| 2026-08-28 | Arnold C Hanish | Director | Mixed | — | $17.02 | -$53.6K | EDGAR |
| 2026-08-25 | David J. Borges | VP, Finance & CAO | Mixed | — | $11.22 | -$168.9K | EDGAR |
| 2026-08-21 | Thomas J. Cable | Director | Mixed | — | $10.71 | -$232.3K | EDGAR |
| 2026-08-18 | Joseph L Schocken | Director | Grant (A) | +30,000 opt | — | EDGAR | |
| 2026-08-17 | David J. Borges | VP, Finance & CAO | Mixed | — | $10.44 | -$65.1K | EDGAR |
| 2026-07-24 | David J. Borges | VP, Finance & CAO | Grant (A) | +105,000 opt | — | EDGAR | |
| 2026-07-24 | Gregory A MD Demopulos | Chairman, CEO & President | Grant (A) | +1,000,000 opt | — | EDGAR | |
| 2026-07-24 | Peter B Cancelmo | VP, General Counsel | Grant (A) | +105,000 opt | — | EDGAR | |
| 2026-06-22 | Arnold C Hanish | Director | Grant (A) | +15,000 opt | — | EDGAR | |
| 2026-06-22 | Peter A MD Demopulos | Director | Grant (A) | +15,000 opt | — | EDGAR | |
| 2026-06-22 | Leroy E. MD PhD Hood | Director | Grant (A) | +15,000 opt | — | EDGAR | |
| 2026-06-22 | Rajiv Shah | Director | Grant (A) | +15,000 opt | — | EDGAR | |
| 2026-06-22 | Thomas J. Cable | Director | Grant (A) | +15,000 opt | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
OMER Insider Holdings
8 insiders · @ $16.51
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Gregory A MD Demopulos | Chairman, CEO & President | 2,126,986 | $35.12M | -$10.36M | 34 | 2026-07-24 |
| 2 | Peter A MD Demopulos | Director | 372,898 | $6.16M | $465.1K | 27 | 2026-06-22 |
| 3 | Leroy E. MD PhD Hood | Director | 74,390 | $1.23M | $0 | 23 | 2026-06-22 |
| 4 | Thomas J. Cable | Director | 42,567 | $702.8K | -$1.33M | 42 | 2026-08-21 |
| 5 | Arnold C Hanish | Director | 17,400 | $287.3K | -$303.2K | 19 | 2026-08-28 |
| 6 | Thomas F. Bumol | Director | 10,000 | $165.1K | $0 | 10 | 2026-06-22 |
| 7 | David J. Borges | VP, Finance & CAO | 10,000 | $165.1K | -$1.46M | 6 | 2026-09-24 |
| 8 | Peter B Cancelmo | VP, General Counsel | 200 | $3.3K | -$929.7K | 10 | 2026-09-01 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
OMER Board & Officers
As of SEC filings through Sep 24, 2026Directors 9
- Leroy E. MD PhD Hood · since Oct 7, 2009
- Peter A MD Demopulos · since Oct 7, 2009
- Thomas J. Cable · since Oct 7, 2009
- Arnold C Hanish · since Sep 26, 2012
- Rajiv Shah · since Jun 14, 2015
- Thomas F. Bumol · since Feb 9, 2019
- Diana T. Perkinson · since May 12, 2023
- Gregory A MD Demopulos · listed since Apr 2024
- Joseph L Schocken · since Aug 12, 2026
Officers 3
- Gregory A MD Demopulos · Chairman, CEO & President · listed since Apr 2010
- Peter B Cancelmo · VP, General Counsel · listed since Sep 2022
- David J. Borges · VP, Finance & CAO · since Jun 30, 2024
Changes in the last 10 years (11)
| Aug 12, 2026 | Joseph L Schocken became a director |
| Jun 30, 2024 | David J. Borges became VP, Finance & CAO |
| Apr 29, 2024 | Gregory A MD Demopulos first listed as a director in an SEC filing |
| Sep 27, 2023 | Gregory A MD Demopulos no longer listed as a director in SEC filings |
| May 12, 2023 | Diana T. Perkinson became a director |
| Sep 23, 2022 | Peter B Cancelmo listed as VP, General Counsel (previously VP, Gen. Counsel & Corp. Sec.) in SEC filings |
| Feb 14, 2022 | Ray Aspiri reported in an SEC filing no longer being a director |
| Mar 3, 2020 | Peter B Cancelmo listed as VP, Gen. Counsel & Corp. Sec. (previously VP, General Counsel and Corporate Secretary) in SEC filings |
| Feb 10, 2020 | Kurt Zumwalt became a director |
| Jun 10, 2019 | Peter B Cancelmo became VP, General Counsel and Corporate Secretary |
| Feb 9, 2019 | Thomas F. Bumol became a director |
Not reported recently (3)
- Michael A Jacobsen · Last reported as VP Finance and CAO in an SEC filing dated Apr 29, 2024
- Kurt Zumwalt · Last reported as a director in an SEC filing dated Sep 23, 2022
- Marcia S. Kelbon · Last reported as VP Patent and General Counsel in an SEC filing dated Jun 11, 2019
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
OMER Proposed Insider Sales (Form 144)
Latest: 2026-09-23
? Form 144 Guide
Last 30d:
2 filings
· $499K notice value
· Last 90d:
9 filings
· $2.3M notice value
· 4 unique filers
· 44% under 10b5-1 plans
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
Top 90-day filers:
PETER CANCELMO (2, $930K) · DAVID BORGES (4, $771K) · ARNOLD HANISH (2, $284K) · THOMAS CABLE (1, $277K)
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-09-23 | DAVID BORGES | Officer | 14,927 | $314.2K | 2026-09-23 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-09-22 | DAVID BORGES | Officer | 10,000 | $184.9K | 2026-09-22 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-08-31 | PETER CANCELMO | Officer | 25,000 | $463.5K | 2026-08-31 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-08-28 | PETER CANCELMO | Officer | 25,000 | $466.1K | 2026-08-28 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-08-27 | ARNOLD HANISH | Director | 10,000 | $189.5K | 2026-08-27 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-08-26 | ARNOLD HANISH | Director | 5,000 | $94.1K | 2026-08-26 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-08-21 | DAVID BORGES | Officer | 10,906 | $203.2K | 2026-08-21 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-08-20 | THOMAS CABLE | Director | 15,000 | $276.8K | 2026-08-20 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
| 2026-08-13 | DAVID BORGES | Officer | 5,000 | $68.5K | 2026-08-13 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-05-22 | Thomas Cable | Director | 7,500 | $89.7K | 2026-05-22 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
45 ETFs hold OMER
25 shown · $142.36M total exposure · 0.03% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $41.4M | — | 2026-09-30 |
| 2 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.04% | $29.3M | $74.2B | 2026-10-21 |
| 3 | VXF Vanguard Extended Market ETF | Vanguard | 0.02% | $15.6M | — | 2026-09-30 |
| 4 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.05% | $8.0M | — | 2026-09-30 |
| 5 | XPH State Street® SPDR® S&P® Pharmaceuticals ETF | SPDR (State Street) | 1.70% | $7.6M | $450.9M | 2026-10-21 |
| 6 | IWN iShares Russell 2000 Value ETF | iShares (BlackRock) | 0.05% | $6.9M | $13.9B | 2026-10-21 |
| 7 | VFMO Vanguard U.S. Momentum Factor ETF | Vanguard | 0.22% | $4.2M | — | 2026-10-21 |
| 8 | IWO iShares Russell 2000 Growth ETF | iShares (BlackRock) | 0.03% | $4.1M | $13.6B | 2026-10-21 |
| 9 | VHT Vanguard Health Care ETF | Vanguard | 0.02% | $4.0M | — | 2026-09-30 |
| 10 | IHE iShares U.S. Pharmaceuticals ETF | iShares (BlackRock) | 0.26% | $4.0M | $1.6B | 2026-10-21 |
| 11 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.02% | $3.8M | — | 2026-05-31 |
| 12 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.29% | $3.6M | $1.2B | 2026-10-21 |
| 13 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.00% | $1.9M | $96.2B | 2026-10-21 |
| 14 | BBP Virtus Biotech Etf | Nport | 1.87% | $1.8M | — | 2026-07-31 |
| 15 | PRFZ Invesco RAFI US 1500 Small-Mid ETF | Nport | 0.05% | $1.3M | — | 2026-07-31 |
| 16 | VTWV Vanguard Russell 2000 Value ETF | Vanguard | 0.06% | $794,025 | — | 2026-09-30 |
| 17 | RSSL Global X Russell 2000 ETF | Global X | 0.04% | $587,318 | — | 2026-10-22 |
| 18 | VTWG Vanguard Russell 2000 Growth ETF | Vanguard | 0.03% | $563,622 | — | 2026-09-30 |
| 19 | FHLC Fidelity MSCI Health Care Index ETF | Fidelity | 0.01% | $562,710 | $3.8B | 2026-10-21 |
| 20 | SEIS SEI Select Small Cap ETF | Nport | 0.09% | $538,665 | — | 2026-06-30 |
| 21 | SCHB Schwab U.S. Broad Market ETF | Nport | 0.00% | $524,334 | — | 2026-05-31 |
| 22 | OPTZ Optimize Strategy Index ETF | Nport | 0.13% | $363,986 | — | 2026-06-30 |
| 23 | ONEQ Fidelity Nasdaq Composite Index ETF | Fidelity | 0.00% | $350,988 | $11.0B | 2026-10-21 |
| 24 | IWV iShares Russell 3000 ETF | iShares (BlackRock) | 0.00% | $326,420 | $20.4B | 2026-10-21 |
| 25 | FSML Franklin Small Cap Enhanced ETF | Franklin | 0.21% | $314,844 | $150.6M | 2026-10-22 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
10.88
TTM Diluted EPS
$1.52
TTM Revenue
$38.42M
TTM Net Income
$124.83M
TTM Op. Cash Flow
$-68.67M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $28.53M | $13.23M | $0.15 | $4.15M |
| Q1 '26 | 2026-03-31 | $9.89M | $56.06M | $0.62 | $-14.51M |
| Q4 '25 | 2025-12-31 | — | $86.45M | $1.42 | $-39.84M |
| Q3 '25 | 2025-09-30 | — | $-30.92M | $-0.47 | $-18.47M |
| Q2 '25 | 2025-06-30 | $0.00 | $-25.42M | $-0.43 | $-21.94M |
| Q1 '25 | 2025-03-31 | — | $-33.46M | $-0.58 | $-35.84M |
| Q4 '24 | 2024-12-31 | — | $-31.36M | $-0.55 | $-28.98M |
| Q3 '24 | 2024-09-30 | — | $-32.23M | $-0.56 | $-32.06M |
| Q2 '24 | 2024-06-30 | — | $-56.04M | $-0.97 | $-45.98M |
| Q1 '24 | 2024-03-31 | — | $-37.18M | $-0.63 | $-41.78M |
| Q4 '23 | 2023-12-31 | — | $-9.07M | $-0.15 | $-34.83M |
| Q3 '23 | 2023-09-30 | — | $-37.75M | $-0.60 | $-32.65M |
Q2 2026 • period ending 2026-06-30 • filed 2026-08-12
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
10.88
P/B
—
P/S
34.12
EV/EBITDA
—
EV/Sales
35.16
ROE
—
ROA
43.5%
Div Yield
0.00%
FCF Yield
-5.24%
Debt/Equity
—
Current Ratio
—
Market Cap
$1.31B
as of 2026-10-23
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
11.38M
SI % of Float
17.73%
Days to Cover
6.95
Short Vol Ratio
60.6%
Free Float
64.19M
Float %
88.7%
Short interest 2026-09-30 • Short volume 2026-10-22 • Float 2026-09-22